Eric Muneio, DO
Physical Medicine & Rehabilitation · Baltimore, MDNPI 1982109427
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,179 of the $1,554 with a category attached, or 75.9%. 8 manufacturers reported payments, led by Relievant Medsystems, Inc. at 26.3% of the total. Reporting peaked in 2023 at $699 and has fallen 55.7% since, to $309 in 2025.
Across 23 payments — averaging $67.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Relievant Medsystems, Inc.$409
- Boston Scientific$377
- Saluda Medical Americas, Inc.$205
- SPR Therapeutics, Inc$203
- Stratus Medical, LLC$163
- Curonix LLC$139
- plus $57 from 2 others
What the payments were for
- Travel & lodging$37524%
- Food & beverage$1,17976%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Relievant Medsystems, Inc. | 2 | $409 |
| Boston Scientific | 6 | $377 |
| Saluda Medical Americas, Inc. | 4 | $205 |
| SPR Therapeutics, Inc | 4 | $203 |
| Stratus Medical, LLC | 2 | $163 |
| Curonix LLC | 3 | $139 |
| Stryker | 1 | $34 |
| AbbVie | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,554 in reported general payments places this provider in the 75th percentile of 202 physical medicine & rehabilitation providers in Maryland.
See all physical medicine & rehabilitation providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 80 | $1,107 |
| Baclofen | 34 | $872 |
| Diclofenac Sodium | 18 | $785 |
| Meloxicam | 121 | $720 |
| Naloxone Hcl | 12 | $664 |
| Cyclobenzaprine Hcl | 35 | $459 |
| Celecoxib | 17 | $377 |
| Duloxetine Hcl | 26 | $363 |
| Tizanidine Hcl | 21 | $303 |
| Methylprednisolone | 42 | $251 |
| Pregabalin | 23 | $129 |
| Oxycodone Hcl | 21 | $128 |
| Diazepam | 15 | $35 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Baltimore
- Akhil ChhatreBaltimore$169K
- Ronald ShinBaltimore$19K
- Mustafa BroachwalaBaltimore$17K
- Gerard LimerickBaltimore$12K
- Marisa FlavinBaltimore$5K
- Tae Hwan ChungBaltimore$3K
- Edward SorianoBaltimore$3K
- Mariam KeramatiBaltimore$2K
- Scott BrownBaltimore$2K
- Eric BuchnerBaltimore$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.